Identification and Functional Characterization of Human Cd4+Cd25+ T Cells with Regulatory Properties Isolated from Peripheral Blood
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
A subpopulation of peripheral human CD4+CD25+ T cells that expresses CD45RO, histocompatibility leukocyte antigen DR, and intracellular cytotoxic T lymphocyte–associated antigen (CTLA) 4 does not expand after stimulation and markedly suppresses the expansion of conventional T cells in a contact-dependent manner. After activation, CD4+CD25+ T cells express CTLA-4 on the surface detectable for several weeks. These cells show a G1/G0 cell cycle arrest and no production of interleukin (IL)-2, IL-4, or interferon (IFN)-γ on either protein or mRNA levels. The anergic state of CD4+CD25+ T cells is not reversible by the addition of anti-CD28, anti–CTLA-4, anti–transforming growth factor β, or anti–IL-10 antibody. However, the refractory state of CD4+CD25+ T cells was partially reversible by the addition of IL-2 or IL-4. These data demonstrate that human blood contains a resident T cell population with potent regulatory properties.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Park, J.-H., Adoro, S., Guinter, T., Erman, B., Alag, A. S., Catalfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608
Thornton, A. M., & Shevach, E. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.287 · Cited by 2,639
Takahashi, T., Tagami, T., Yamazaki, S., Uede, T., Shimizu, J., Sakaguchi, N., Mak, T. W., & Sakaguchi, S. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.2.303 · Cited by 2,233 · cited 5×
“Detailed characterization in vitro revealed that their suppressive capacity is mediated by direct T cell–T cell contact, but not by cytokines like IL-10 and TGF- (5, 8, 9).”
BackgroundInfluentialRead, S., Malmström, V., & Powrie, F. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.2.295 · Cited by 2,205
Salomon, B., Lenschow, D. J., Rhee, L., Ashourian, N., Singh, B., Sharpe, A., & Bluestone, J. A. (2000) · Immunity · doi:10.1016/s1074-7613(00)80195-8 · Cited by 2,081
Takahashi, T., Kuniyasu, Y., Toda, M., Sakaguchi, N., Itoh, M., Iwata, M., Shimizu, J., & Sakaguchi, S. (1998) · International Immunology · doi:10.1093/intimm/10.12.1969 · Cited by 1,568
Jonuleit, H., Schmitt, E., Schuler, G., Knop, J., & Enk, A. H. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.9.1213 · Cited by 1,538
Self-citationRegulatory T Cells in Autoimmmunity
Shevach, E. M. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.423 · Cited by 1,236
Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific
Thornton, A. M., & Shevach, E. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.1.183 · Cited by 1,229 · cited 7×
“Here we show, using RT-PCR for cytokine mRNA analysis of human CD4 CD25 T cells, that only mRNA signals for TGF- and IL-10 were detectable in resting and activated CD4 CD25 T cells.”
BackgroundInfluential
Cited by
Items 101–183 of 183
Polyglandular Autoimmune Syndromes: Immunogenetics and Long-Term Follow-Up
Dittmar, M., & Kahaly, G. J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021845 · Cited by 367
Hering, B. J., Kandaswamy, R., Harmon, J. V., Ansite, J. D., Clemmings, S. M., Sakai, T., Paraskevas, S., Eckman, P. M., Sageshima, J., Nakano, M., et al. (2004) · American Journal of Transplantation · doi:10.1046/j.1600-6143.2003.00351.x · Cited by 367
Walther, M., Tongren, J. E., Andrews, L., Korbel, D., King, E., Fletcher, H., Andersen, R. F., Bejon, P., Thompson, F., Dunachie, S. J., et al. (2005) · Immunity · doi:10.1016/j.immuni.2005.08.006 · Cited by 366
Zhang, X. (2004) · International Immunology · doi:10.1093/intimm/dxh029 · Cited by 363
Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia
Ruprecht, C. R., Gattorno, M., Ferlito, F., Gregorio, A., Martini, A., Lanzavecchia, A., & Sallusto, F. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050085 · Cited by 361
Camisaschi, C., Casati, C., Rini, F., Perego, M., De Filippo, A., Triebel, F., Parmiani, G., Belli, F., Rivoltini, L., & Castelli, C. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903879 · Cited by 350
“Natural Treg cells, upon TCR engagement (15, 16), exert their immunosuppressive functions in a contact-dependent fashion.”
BackgroundDudley, M. E., Wunderlich, J. R., Yang, J. C., Hwu, P., Schwartzentruber, D. J., Topalian, S. L., Sherry, R. M., Marincola, F. M., Leitman, S. F., Seipp, C. A., et al. (2002) · Journal of Immunotherapy · doi:10.1097/00002371-200205000-00007 · Cited by 357
Kriegel, M. A., Lohmann, T., Gabler, C., Blank, N., Kalden, J. R., & Lorenz, H.-M. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20032158 · Cited by 351
Human FoxP3+ regulatory T cells in systemic autoimmune diseases
Miyara, M., Gorochov, G., Ehrenstein, M., Musset, L., Sakaguchi, S., & Amoura, Z. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.05.004 · Cited by 342
Strauss, L., Whiteside, T. L., Knights, A., Bergmann, C., Knuth, A., & Zippelius, A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.1.320 · Cited by 336
Altered status of CD4+CD25+ regulatory T cells in patients with acute coronary syndromes
Mor, A., Luboshits, G., Planer, D., Keren, G., & George, J. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl222 · Cited by 336
Ladoire, S., Martin, F., & Ghiringhelli, F. (2011) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-011-1046-y · Cited by 331
Heat shock protein 60 enhances CD4+ CD25+ regulatory T cell function via innate TLR2 signaling
Zanin-Zhorov, A. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28423 · Cited by 323
RetractedMöttönen, M., Heikkinen, J., Mustonen, L., Isomäki, P., Luukkainen, R., & Lassila, O. (2005) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2005.02754.x · Cited by 320
High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells
Manavalan, J. S., Rossi, P. C., Vlad, G., Piazza, F., Yarilina, A., Cortesini, R., Mancini, D., & Suciu-Foca, N. (2003) · Transplant Immunology · doi:10.1016/s0966-3274(03)00058-3 · Cited by 319
T regulatory cells in atopic dermatitis and subversion of their activity by superantigens
Ou, L.-S., Goleva, E., Hall, C., & Leung, D. Y. M. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.01.772 · Cited by 319
Shima, T., Sasaki, Y., Itoh, M., Nakashima, A., Ishii, N., Sugamura, K., & Saito, S. (2010) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2010.02.006 · Cited by 317
Robinson, D. S., Larché, M., & Durham, S. R. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200423595 · Cited by 313
Lundgren, A., Suri-Payer, E., Enarsson, K., Svennerholm, A.-M., & Lundin, B. S. (2003) · Infection and Immunity · doi:10.1128/iai.71.4.1755-1762.2003 · Cited by 312
Andaloussi, A. E., & Lesniak, M. S. (2006) · Neuro-Oncology · doi:10.1215/15228517-2006-006 · Cited by 311
Immunomodulatory effects of cyclophosphamide and implementations for vaccine design
Sistigu, A., Viaud, S., Chaput, N., Bracci, L., Proietti, E., & Zitvogel, L. (2011) · Seminars in Immunopathology · doi:10.1007/s00281-011-0245-0 · Cited by 305
Beyer, M., Kochanek, M., Giese, T., Endl, E., Weihrauch, M. R., Knolle, P. A., Classen, S., & Schultze, J. L. (2006) · Blood · doi:10.1182/blood-2005-09-3671 · Cited by 301
HIV Infection of Naturally Occurring and Genetically Reprogrammed Human Regulatory T-cells
Oswald-Richter, K., Grill, S. M., Shariat, N., Leelawong, M., Sundrud, M. S., Haas, D. W., & Unutmaz, D. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020198 · Cited by 301
Sawitzki, B., Kingsley, C. I., Oliveira, V., Karim, M., Herber, M., & Wood, K. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050419 · Cited by 297
Regulatory T cells in the treatment of disease
Sharabi, A., Tsokos, M. G., Ding, Y., Malek, T. R., Klatzmann, D., & Tsokos, G. C. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.148 · Cited by 297
What are regulatory T cells (Treg) regulating in cancer and why?
Whiteside, T. L. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.03.004 · Cited by 291
Lim, H. W., Hillsamer, P., & Kim, C. H. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22325 · Cited by 288
Kono, K., Kawaida, H., Takahashi, A., Sugai, H., Mimura, K., Miyagawa, N., Omata, H., & Fujii, H. (2006) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-005-0092-8 · Cited by 288
De novo generation of antigen-specific CD4+CD25+regulatory T cells from human CD4+CD25–cells
Walker, M. R., Carson, B. D., Nepom, G. T., Ziegler, S. F., & Buckner, J. H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407691102 · Cited by 285
Control of Autoimmunity by Naturally Arising Regulatory CD4+ T Cells
(2003) · Advances in Immunology · doi:10.1016/s0065-2776(03)81008-8 · Cited by 283
Golgher, D., Jones, E., Powrie, F., Elliott, T., & Gallimore, A. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200211)32:11<3267::aid-immu3267>3.0.co;2-1 · Cited by 282
Decreased CD4+CD25+ T Cells in Peripheral Blood of Patients with Systemic Lupus Erythematosus
Liu, M. ‐., Wang, C. ‐., Fung, L. ‐., & Wu, C. ‐. (2004) · Scandinavian Journal of Immunology · doi:10.1111/j.0300-9475.2004.01370.x · Cited by 282
Strauss, L., Bergmann, C., Gooding, W., Johnson, J. T., & Whiteside, T. L. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1403 · Cited by 281
What is Good’s syndrome? Immunological abnormalities in patients with thymoma
Kelleher, P., & Misbah, S. A. (2003) · Journal of Clinical Pathology · doi:10.1136/jcp.56.1.12 · Cited by 281
Role of regulatory T cells in psoriasis pathogenesis and treatment
Nussbaum, L., Chen, Y. L., & Ogg, G. S. (2021) · British Journal of Dermatology · doi:10.1111/bjd.19380 · Cited by 279
Godfrey, W. R., Ge, Y. G., Spoden, D. J., Levine, B. L., June, C. H., Blazar, B. R., & Porter, S. B. (2004) · Blood · doi:10.1182/blood-2004-01-0151 · Cited by 277
Kondělková, K., Vokurková, D., Krejsek, J., Borská, L., Fiala, Z., & Andrýs, C. (2010) · Acta Medica (Hradec Kralove, Czech Republic) · doi:10.14712/18059694.2016.63 · Cited by 276
Schaefer, C., Kim, G. G., Albers, A., Hoermann, K., Myers, E. N., & Whiteside, T. L. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602407 · Cited by 271
Compromised lymphocytes infiltrate hepatocellular carcinoma: The role of T‐regulatory cells†‡
Unitt, E., Rushbrook, S. M., Marshall, A., Davies, S., Gibbs, P., Morris, L. S., Coleman, N., & Alexander, G. J. M. (2005) · Hepatology · doi:10.1002/hep.20644 · Cited by 267
Fischer, K., Voelkl, S., Heymann, J., Przybylski, G. K., Mondal, K., Laumer, M., Kunz-Schughart, L., Schmidt, C. A., Andreesen, R., & Mackensen, A. (2005) · Blood · doi:10.1182/blood-2004-07-2583 · Cited by 266
Human regulatory T cells and their role in autoimmune disease
Baecher‐Allan, C., & Hafler, D. A. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00417.x · Cited by 266
CD4+CD25bright T Cells in Human Intestinal Lamina Propria as Regulatory Cells
Makita, S., Kanai, T., Oshima, S., Uraushihara, K., Totsuka, T., Sawada, T., Nakamura, T., Koganei, K., Fukushima, T., & Watanabe, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.5.3119 · Cited by 264
Immunoregulatory T cells in tumor immunity
Terabe, M., & Berzofsky, J. A. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2004.01.010 · Cited by 264
Inhibition of Human CD4+CD25+high Regulatory T Cell Function
Baecher-Allan, C., Viglietta, V., & Hafler, D. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.11.6210 · Cited by 262
FOXP3 modifies the phenotypic and functional properties of regulatory T cells
Campbell, D. J., & Ziegler, S. F. (2007) · Nature Reviews Immunology · doi:10.1038/nri2061 · Cited by 261
Lim, H. W., Hillsamer, P., & Kim, C. H. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422325 · Cited by 260
Collison, L. W., Pillai, M. R., Chaturvedi, V., & Vignali, D. A. A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803646 · Cited by 259
Gandhi, M. K., Lambley, E., Duraiswamy, J., Dua, U., Smith, C., Elliott, S., Gill, D., Marlton, P., Seymour, J., & Khanna, R. (2006) · Blood · doi:10.1182/blood-2006-04-015164 · Cited by 255
Manavalan, J. S., Kim-Schulze, S., Scotto, L., Naiyer, A. J., Vlad, G., Colombo, P. C., Marboe, C., Mancini, D., Cortesini, R., & Suciu-Foca, N. (2004) · International Immunology · doi:10.1093/intimm/dxh107 · Cited by 256
Beissert, S., Schwarz, A., & Schwarz, T. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700004 · Cited by 255
Joetham, A., Takada, K., Taube, C., Miyahara, N., Matsubara, S., Koya, T., Rha, Y.-H., Dakhama, A., & Gelfand, E. W. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.3.1433 · Cited by 239
van Santen, H.-M., Benoist, C., & Mathis, D. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041022 · Cited by 236
Lawson, C. A., Brown, A. K., Bejarano, V., Douglas, S. H., Burgoyne, C. H., Greenstein, A. S., Boylston, A. W., Emery, P., Ponchel, F., & Isaacs, J. D. (2006) · Rheumatology · doi:10.1093/rheumatology/kel089 · Cited by 234
Global impairment of CD4+CD25+FOXP3+ regulatory T cells in idiopathic pulmonary fibrosis
Kotsianidis, I., Nakou, E., Bouchliou, I., Tzouvelekis, A., Spanoudakis, E., Steiropoulos, P., Sotiriou, I., Aidinis, V., Margaritis, D., Tsatalas, C., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200812-1936oc · Cited by 230
Clinical evidence for the safety of GAD65 immunomodulation in adult-onset autoimmune diabetes
Agardh, C.-D., Cilio, C. M., Lethagen, Å., Lynch, K., Leslie, R. D. G., Palmér, M., Harris, R. A., Robertson, J. A., & Lernmark, Å. (2005) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2004.12.003 · Cited by 226
Grindebacke, H., Wing, K., Andersson, A. ‐., Suri‐Payer, E., Rak, S., & Rudin, A. (2004) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2004.02067.x · Cited by 215
In Vitro Treg Suppression Assays
Collison, L. W., & Vignali, D. A. A. (2011) · Methods in Molecular Biology · doi:10.1007/978-1-61737-979-6_2 · Cited by 211
Cavani, A., Nasorri, F., Ottaviani, C., Sebastiani, S., De Pità, O., & Girolomoni, G. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.11.5760 · Cited by 211
Role of regulatory T cells in allergy and asthma
Akbari, O., Stock, P., DeKruyff, R. H., & Umetsu, D. T. (2003) · Current Opinion in Immunology · doi:10.1016/j.coi.2003.09.012 · Cited by 206
Takahata, Y., Nomura, A., Takada, H., Ohga, S., Furuno, K., Hikino, S., Nakayama, H., Sakaguchi, S., & Hara, T. (2004) · Experimental Hematology · doi:10.1016/j.exphem.2004.03.012 · Cited by 206
“Approximately 10% of circulating CD4 T cells express CD25 in normal mice and healthy adult human [23].”
BackgroundCD4+CD25high regulatory T cells in human autoimmune diabetes
Putnam, A. L., Vendrame, F., Dotta, F., & Gottlieb, P. A. (2005) · Journal of Autoimmunity · doi:10.1016/j.jaut.2004.11.004 · Cited by 205
Beyersdorf, N., Gaupp, S., Balbach, K., Schmidt, J., Toyka, K. V., Lin, C.-H., Hanke, T., Hünig, T., Kerkau, T., & Gold, R. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051060 · Cited by 203
Bellinghausen, I., Klostermann, B., Knop, J., & Saloga, J. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.1412 · Cited by 203
Self-citationFeger, U., Tolosa, E., Huang, Y.-H., Waschbisch, A., Biedermann, T., Melms, A., & Wiendl, H. (2007) · Blood · doi:10.1182/blood-2006-11-057125 · Cited by 198
Invasion of the leukocytes into the fetal-maternal interface during pregnancy
Gomez-Lopez, N., Guilbert, L. J., & Olson, D. M. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.1209796 · Cited by 194
“The phenotype of the Treg subpopulation includes CD25 CD4 cells, which are a specialized T cell population that not only suppresses autoaggressive immune responses but also may prevent graft rejection as a result of transplantation antigen intolerance [6, 75, 76].”
BackgroundRegulatory T-cell therapy: is it ready for the clinic?
Bluestone, J. A. (2005) · Nature Reviews Immunology · doi:10.1038/nri1574 · Cited by 189
Circulating Naïve and CD4+CD25high Regulatory T Cells in Patients With Autoimmune Pancreatitis
Miyoshi, H., Uchida, K., Taniguchi, T., Yazumi, S., Matsushita, M., Takaoka, M., & Okazaki, K. (2008) · Pancreas · doi:10.1097/mpa.0b013e3181577553 · Cited by 186
Efficient expansion of regulatory T cells in vitro and in vivo with a CD28 superagonist
Lin, C., & Hünig, T. (2003) · European Journal of Immunology · doi:10.1002/eji.200323570 · Cited by 184
Functional analysis of highly defined, FACS-isolated populations of human regulatory CD4CD25 T cells
BAECHERALLAN, C., WOLF, E., & HAFLER, D. (2005) · Clinical Immunology · doi:10.1016/j.clim.2005.02.018 · Cited by 180
Elinav, E., Waks, T., & Eshhar, Z. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.060 · Cited by 180
New perspectives on the biology of acute GVHD
Paczesny, S., Hanauer, D., Sun, Y., & Reddy, P. (2010) · Bone Marrow Transplantation · doi:10.1038/bmt.2009.328 · Cited by 179
Sleep-dependent activity of T cells and regulatory T cells
Bollinger, T., Bollinger, A., Skrum, L., Dimitrov, S., Lange, T., & Solbach, W. (2009) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2008.03822.x · Cited by 167
Filaci, G., Fravega, M., Negrini, S., Procopio, F., Fenoglio, D., Rizzi, M., Brenci, S., Contini, P., Olive, D., Ghio, M., et al. (2004) · Human Immunology · doi:10.1016/j.humimm.2003.12.001 · Cited by 163
Suppression assays with human T regulatory cells: A technical guide
McMurchy, A. N., & Levings, M. K. (2012) · European Journal of Immunology · doi:10.1002/eji.201141651 · Cited by 147
Regulatory T cells and tolerogenic dendritic cells: from basic biology to clinical applications
Rutella, S., & Lemoli, R. M. (2004) · Immunology Letters · doi:10.1016/j.imlet.2004.04.015 · Cited by 147
Karim, M., Feng, G., Wood, K. J., & Bushell, A. R. (2005) · Blood · doi:10.1182/blood-2004-10-3888 · Cited by 141
CTLA-4 is expressed by human monocyte-derived dendritic cells and regulates their functions
Laurent, S., Carrega, P., Saverino, D., Piccioli, P., Camoriano, M., Morabito, A., Dozin, B., Fontana, V., Simone, R., Mortara, L., et al. (2010) · Human Immunology · doi:10.1016/j.humimm.2010.07.007 · Cited by 121
Heavy chain ferritin activates regulatory T cells by induction of changes in dendritic cells
Gray, C. P., Arosio, P., & Hersey, P. (2002) · Blood · doi:10.1182/blood.v99.9.3326 · Cited by 118
Leng, S., Xue, Q.-L., Huang, Y., Semba, R., Chaves, P., Bandeen-Roche, K., Fried, L., & Walston, J. (2005) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/60.2.195 · Cited by 86
Critical Role of Transcription Factor PU.1 in the Expression of CD80 and CD86 on Dendritic Cells
Kanada, S., Nishiyama, C., Nakano, N., Suzuki, R., Maeda, K., Hara, M., Kitamura, N., Ogawa, H., & Okumura, K. (2011) · Blood · doi:10.1182/blood-2010-06-291898 · Cited by 73
The dark side of Tregs during aging
Palatella, M., Guillaume, S. M., Linterman, M. A., & Huehn, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.940705 · Cited by 58
Posselt, R., Erlenbach-Wünsch, K., Haas, M., Jeßberger, J., Büttner-Herold, M., Haderlein, M., Hecht, M., Hartmann, A., Fietkau, R., & Distel, L. V. (2016) · Oncotarget · doi:10.18632/oncotarget.11039 · Cited by 38
Immunotherapy Resistance in Glioblastoma
Wang, E. J., Chen, J.-S., Jain, S., Morshed, R. A., Haddad, A. F., Gill, S., Beniwal, A. S., & Aghi, M. K. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.750675 · Cited by 34
Metadata
- Authors
- Jonuleit, H., Schmitt, E., Stassen, M., Tuettenberg, A., Knop, J., & Enk, A. H.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2001-06-04
- Volume
- 193
- Issue
- 11
- Pages
- 1285-1294
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2148245227
- Cited by
- 1,255
- References
- 23
- FWCI
- 28.50
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.